WorldQuant Millennium Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

WorldQuant Millennium Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.16M	Buy	+34,315	New	+$1.14M	﹤0.01%	574
2025 Q4	–	Sell	-149,282	Closed	-$3.02M	–	646
2025 Q3	$3.02M	Sell	149,282 -12,214	-8%	-$215K	0.01%	338
2025 Q2	$2.71M	Sell	161,496 -186,647	-54%	-$3.01M	0.01%	340
2025 Q1	$5.35M	Buy	348,143 +123,169	+55%	+$2.2M	0.03%	291
2024 Q4	$4.96M	Buy	+224,974	New	+$4.09M	0.03%	293
2018 Q4	–	Sell	-358,032	Closed	-$7.71M	–	321
2018 Q3	$7.71M	Buy	358,032 +293,485	+455%	+$6.81M	0.26%	132
2018 Q2	$1.57M	Buy	+64,547	New	+$1.32M	0.06%	210

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

WorldQuant Millennium Advisors's TEVA Position: Q2 2026 in Review

WorldQuant Millennium Advisors opened a new position in Teva Pharmaceuticals (TEVA) in Q2 2026: 34,315 shares worth $1.16M. The stake represents ﹤0.01% of the portfolio and ranks #574 among its holdings. This is a return to the name: WorldQuant Millennium Advisors previously reported a position in TEVA as recently as Q3 2025.

WorldQuant Millennium Advisors first reported a position in TEVA in Q2 2018 and has held it in 7 quarters since. The position peaked at $7.71M in Q3 2018. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

WorldQuant Millennium Advisors held 34,315 shares of Teva Pharmaceuticals worth $1.16M as of Q2 2026.
Teva Pharmaceuticals was a new WorldQuant Millennium Advisors position in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of WorldQuant Millennium Advisors's portfolio in Q2 2026, its #574 holding.
WorldQuant Millennium Advisors first reported a position in Teva Pharmaceuticals in Q2 2018 and has held it in 7 quarters since.
WorldQuant Millennium Advisors's Teva Pharmaceuticals position peaked at $7.71M in Q3 2018.
675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.